Project Grant R37CA283041
Award Date
9/18/24
Completion Date
8/31/29
Dollars Obligated
$765K
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
New York, NY 10065, USA
Similar Awards
This Project Grant award from the National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), aims to establish the feasibility of gastric cancer screening in diverse high-risk populations in the United States. The $564,414 award will support two key activities: Development and validation of a predictive model based on electronic health record (EHR) data to accurately identify individuals at high risk for gastric cancer. This will involve refining...
This Project Grant award of $125,783 from the National Cancer Institute (NCI) under the Cancer Research Manpower (CFDA 93.398) program supports research to investigate the mechanisms driving advanced gastric adenocarcinoma (GAC) progression, with a focus on CDH1-inactivated subtypes. The key research objectives are to determine the intrinsic (SOX4 and EZH2-mediated) and extrinsic (immune evasion) dysregulation mechanisms associated with CDH1 loss in advanced GAC, as well as to explore...
The National Cancer Institute (NCI) awarded a $455,111 Project Grant under CFDA 93.393 "Cancer Cause and Prevention Research" to the Sloan-Kettering Institute for Cancer Research in New York. The 2-year grant, awarded on September 5, 2023, will support research to "Leverage the Hidden Genome to Recover the Missing Heritability of Cancer." The project aims to 1) estimate additional heritability that can be explained by the "hidden genome" (regions of unknown...
This $734,785 Project Grant awarded by the National Cancer Institute (NCI), under the federal Cancer Cause and Prevention Research program (CFDA 93.393), funds a proteogenomic study to identify proteins associated with breast cancer risk. The primary awardee, Vanderbilt University Medical Center, will conduct a well-powered proteome-wide association study (PWAS) by integrating genomics and proteomics data from breast tissue samples. This will help uncover putative target proteins for breast...
The National Cancer Institute (NCI) awarded a Project Grant under the Cancer Research Manpower (CFDA 93.398) program to the Sloan-Kettering Institute for Cancer Research. The $256,487 grant, effective August 13, 2024, supports a 5-year research project to develop multimodal predictive models for non-small cell lung cancer (NSCLC) using real-world data sources such as circulating tumor DNA sequencing, tumor genomics, and clinician notes. The goal is to improve risk stratification and clinical...
This Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) is providing $661,831 to the University of North Carolina at Chapel Hill to create the Human Cancer Metabolome Atlas (HCMA). The HCMA will be an open-access database of metabolomics data from over 2,000 patient-derived tumor samples, which will help researchers better understand the role of tumor metabolism in cancer. Under this 5-year award, the University of North Carolina will...
This federal Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) provides $606,839 to Weill Medical College of Cornell University to conduct research on the role of gut microbiota amino acid metabolism in cancer. The key objectives are to: 1) identify microbes and their genes that deplete intestinal amino acids and evaluate their impact on the tumor microenvironment and cancer progression; 2) elucidate the molecular mechanisms by which microbiota...
This Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $183,758 to Vanderbilt University to investigate the role of the transcription factor SOX9 in the development of gastric cancer. The research aims to: Determine if SOX9 is required for chief cells to transdifferentiate into spasmolytic polypeptide-expressing metaplastic (SPEM) cells, which are essential for gastric carcinogenesis. This will be examined using in vitro organoid...
This Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) provides $221,456.00 to the Regents of the University of Minnesota to develop and optimize a novel approach for efficiently enriching microbes from clinical cancer samples. The approach, based on bio-orthogonal non-canonical amino acid tagging (BONCAT) coupled with cell sorting and sensitive mass spectrometry-based metaproteomics, aims to enable deep characterization of microbial...
The National Cancer Institute (NCI) awarded a 5-year, $193,144 Project Grant (CFDA 93.398 - Cancer Research Manpower) to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, effective September 1, 2024. The grant supports a multidisciplinary postdoctoral training program focused on gastrointestinal (GI) cancers, which constitute a significant portion of cancer deaths in the U.S. and worldwide. The program aims to advance the understanding...